Richard J. Napolitano - Feb 1, 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Chief Accounting Officer
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol
TDOC
Transactions as of
Feb 1, 2022
Transactions value $
-$64,813
Form type
4
Date filed
2/3/2022, 03:10 PM
Previous filing
Sep 24, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +2.02K 2.02K Feb 1, 2022 Direct F1
transaction TDOC Common Stock Sale -$64.8K -824 -40.81% $78.66 1.2K Feb 2, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -2.02K -33.33% $0.00 4.04K Feb 1, 2022 Common Stock 2.02K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.